Old Web
English
Sign In
Acemap
>
Paper
>
The PI3K inhibitor copanlisib synergizes with sorafenib to induce cell death in hepatocellular carcinoma (HCC)
The PI3K inhibitor copanlisib synergizes with sorafenib to induce cell death in hepatocellular carcinoma (HCC)
2018
Liangtao Ye
Julia Mayerle
Andreas Ziesch
K Wei
Alexander L. Gerbes
E de Toni
Keywords:
Cancer research
Hepatocellular carcinoma
Copanlisib
Sorafenib
Medicine
Programmed cell death
PI3K/AKT/mTOR pathway
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]